Sort by
Refine Your Search
-
can be found on our website . About ETH Zürich ETH Zurich is one of the world’s leading universities specialising in science and technology. We are renowned for our excellent education, cutting-edge
-
100%, Zurich, fixed-term The Molecular Pharmacology group is a multidisciplinary research team at ETH Zurich, which spans the whole spectrum of pharmacological research from in vitro to in vivo
-
. Our team works on (i) advancing our understanding of mechanotransduction in 3D, (ii) designing hydrogel-based 3D scaffolds with tunable properties, and (iii) using these to design 3D disease models and
-
100%, Zurich, fixed-term The Digital Chemistry Laboratory is led by Prof. Dr. Kjell Jorner at the Institute of Chemical and Bioengineering, within the Department of Chemistry and Applied Biosciences
-
Institute (Dr. Safonova group). Job description Specifically, this project, by combining high throughput experimentation, synthesis of model catalysts, operando characterization, and molecular modelling aims
-
background Investigating gene function using direct in vivo screening is revolutionising the way we study brain biology . We have previously developed AAV-based molecular methods for direct in vivo CRISPR
-
100%, Zurich, fixed-term The Laboratory of Toxicology, led by Professor Shana Sturla, is part of the ETH Department of Health Science & Technology and the Institute for Food, Nutrition and Health
-
The Hardt lab studies Salmonella diarrhea. We are interested in the molecular and cellular mechanisms that explain how the food-borne pathogen colonizes the gut, infects the gut tissue and causes
-
. Uncovering the extent and structure of this diversity requires an exploration of the molecular adaptations that facilitate survival, growth and diversification, alongside the ecological drivers that underpin
-
background Investigating gene function using direct in vivo screening is revolutionising the way we study brain biology . We have previously developed AAV-based molecular methods for direct in vivo CRISPR